|
1
|
Li M, Li J, Ding X, He M and Cheng S:
microRNA and cancer. AAPS J. 12:309–317. 2010. View Article : Google Scholar
|
|
2
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
3
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim YK, Yu J, Han TS, et al: Functional
links between clustered microRNAs: suppression of cell-cycle
inhibitors by microRNA clusters in gastric cancer. Nucleic Acids
Res. 37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fish JE, Santoro MM, Morton SU, et al:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Aurora AB, Johnson BA, et al: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho WC, Chow AS and Au JS: Restoration of
tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung
adenocarcinoma patients with epidermal growth factor receptor
mutation. Eur J Cancer. 45:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng R, Chen X, Yu Y, et al: miR-126
functions as a tumour suppressor in human gastric cancer. Cancer
Lett. 298:50–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Otsubo T, Akiyama Y, Hashimoto Y, Shimada
S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and
contributes to gastric carcinogenesis. PLoS One. 6:e166172011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Tang S, Le SY, et al: Aberrant
expression of oncogenic and tumor-suppressive microRNAs in cervical
cancer is required for cancer cell growth. PLoS One. 3:e25572008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saito Y, Friedman JM, Chihara Y, Egger G,
Chuang JC and Liang G: Epigenetic therapy upregulates the tumor
suppressor microRNA-126 and its host gene EGFL7 in human cancer
cells. Biochem Biophys Res Commun. 379:726–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu S, Gao S, Wang XY and Wang DB:
Expression of miR-126 and Crk in endometriosis: miR-126 may affect
the progression of endometriosis by regulating Crk expression. Arch
Gynecol Obstet. 285:1065–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meister J and Schmidt MH: miR-126 and
miR-126*: new players in cancer. Sci World J.
10:2090–2100. 2010.
|
|
18
|
Sessa R, Seano G, di Blasio L, et al: The
miR-126 regulates angiopoietin-1 signaling and vessel maturation by
targeting p85beta. Biochim Biophys Acta. 1823:1925–1935. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Du YY, Lin YF, et al: The cell
growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res
Commun. 377:136–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Felli N, Felicetti F, Lustri AM, et al:
miR-126&126* restored expressions play a tumor
suppressor role by directly regulating ADAM9 and MMP7 in melanoma.
PLoS One. 8:e568242013.
|
|
21
|
Miko E, Margitai Z, Czimmerer Z, et al:
miR-126 inhibits proliferation of small cell lung cancer cells by
targeting SLC7A5. FEBS Lett. 585:1191–1196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Glover DM, Hagan IM and Tavares AA:
Polo-like kinases: a team that plays throughout mitosis. Genes Dev.
12:3777–3787. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nigg EA: Polo-like kinases: positive
regulators of cell division from start to finish. Curr Opin Cell
Biol. 10:776–783. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warnke S, Kemmler S, Hames RS, et al:
Polo-like kinase-2 is required for centriole duplication in
mammalian cells. Curr Biol. 14:1200–1207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burns TF, Fei P, Scata KA, Dicker DT and
El-Deiry WS: Silencing of the novel p53 target gene Snk/Plk2 leads
to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol
Cell Biol. 23:5556–5571. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eckerdt F, Yuan J and Strebhardt K:
Polo-like kinases and oncogenesis. Oncogene. 24:267–276. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Lu J, Sun M, et al: Distinct
microRNA expression profiles in acute myeloid leukemia with common
translocations. Proc Natl Acad Sci USA. 105:15535–15540. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oglesby IK, Bray IM, Chotirmall SH, et al:
miR-126 is downregulated in cystic fibrosis airway epithelial cells
and regulates TOM1 expression. J Immunol. 184:1702–1709. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
30
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi H, Xu J, Zhang G, et al: Walking the
interactome to identify human miRNA-disease associations through
the functional link between miRNA targets and disease genes. BMC
Syst Biol. 7:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang M, Zhou S, Zhang L, et al: miR-518b
is down-regulated, and involved in cell proliferation and invasion
by targeting Rap1b in esophageal squamous cell carcinoma. FEBS
Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abell K, Bilancio A, Clarkson RW, et al:
Stat3-induced apoptosis requires a molecular switch in PI (3) K
subunit composition. Nat Cell Biol. 7:392–398. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
De Gregorio G, Coppa A, Cosentino C, et
al: The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth
and survival signals. Oncogene. 26:2039–2047. 2007.PubMed/NCBI
|
|
35
|
Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL
and Reddy SA: The PI 3-kinase/Akt signaling pathway is activated
due to aberrant Pten expression and targets transcription factors
NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene.
23:8571–8580. 2004. View Article : Google Scholar : PubMed/NCBI
|
